1. Home
  2. HSAI vs APGE Comparison

HSAI vs APGE Comparison

Compare HSAI & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSAI
    SELLHOLDBUYas of 12 hours ago
  • APGE
    SELLHOLDBUYas of 12 hours ago
  • Stock Information
  • Founded
  • HSAI 2014
  • APGE 2022
  • Country
  • HSAI China
  • APGE United States
  • Employees
  • HSAI N/A
  • APGE N/A
  • Industry
  • HSAI
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HSAI
  • APGE Health Care
  • Exchange
  • HSAI Nasdaq
  • APGE Nasdaq
  • Market Cap
  • HSAI 1.8B
  • APGE 2.1B
  • IPO Year
  • HSAI 2023
  • APGE 2023
  • Fundamental
  • Price
  • HSAI $15.27
  • APGE $32.32
  • Analyst Decision
  • HSAI
  • APGE Strong Buy
  • Analyst Count
  • HSAI 0
  • APGE 4
  • Target Price
  • HSAI N/A
  • APGE $91.33
  • AVG Volume (30 Days)
  • HSAI 6.8M
  • APGE 732.8K
  • Earning Date
  • HSAI 05-19-2025
  • APGE 05-12-2025
  • Dividend Yield
  • HSAI N/A
  • APGE N/A
  • EPS Growth
  • HSAI N/A
  • APGE N/A
  • EPS
  • HSAI N/A
  • APGE N/A
  • Revenue
  • HSAI $284,577,139.00
  • APGE N/A
  • Revenue This Year
  • HSAI $68.02
  • APGE N/A
  • Revenue Next Year
  • HSAI $34.07
  • APGE $795.25
  • P/E Ratio
  • HSAI N/A
  • APGE N/A
  • Revenue Growth
  • HSAI 10.66
  • APGE N/A
  • 52 Week Low
  • HSAI $3.52
  • APGE $29.10
  • 52 Week High
  • HSAI $24.18
  • APGE $63.50
  • Technical
  • Relative Strength Index (RSI)
  • HSAI 42.14
  • APGE 36.19
  • Support Level
  • HSAI $14.06
  • APGE $38.18
  • Resistance Level
  • HSAI $18.68
  • APGE $38.14
  • Average True Range (ATR)
  • HSAI 1.57
  • APGE 2.33
  • MACD
  • HSAI -0.44
  • APGE -0.72
  • Stochastic Oscillator
  • HSAI 13.50
  • APGE 14.29

Stock Price Comparison Chart: HSAI vs APGE

HSAI
APGE
AprilJulyOctober2024AprilJulyOctober2025April0510152025303540455055606570HSAI VS APGE

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. The Group organized its operations into two segments: the LiDAR segment and the gas detection segment, out of which LiDAR segments derives maximum revenue. Geographically, the company operates into North America, Mainland China, Europe and Other regions.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use